May 19, 2017 - Amgen Inc. (AMGN) recently announced the submission of a biologics license application (BLA) to the FDA for its pipeline candidate erenumab (AMG 334) for the prevention of migraine.
May 25, 2017 - Aerie Pharmaceuticals, Inc. (AERI) announced positive primary efficacy results of the 90-day phase III registration trial -- Mercury 2 -- for its pipeline candidate Roclatan.
May 16, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.'s (VRX) diabetes drug, Glumetza, in the U.S.
Jun 21, 2017 - The project on 32 acres at the former Cardinal Gibbons High School site.
Jun 09, 2017 - Mizuho issues rating change for AGN
Jun 29, 2017 - Sarepta Therapeutics, Inc. (SRPT) announced the appointment of Douglas S. Ingram as the new chief executive officer (CEO).
Jul 03, 2017 - Keith Vander Kolk believes health care has become to politicized.
Vander Kolk, the CEO of Saint Agnes Healthcare, says both Republicans and Democrats care too much about who wins and who loses, and are overlooking conversations about the impact of health care legislation and bypassing discussions on actual policy.
On this week's episode of the BaltBizCast, reporter Morgan Eichensher talks to Vander Kolk about the various health care bills floating around Congress, and what the uncertainty means…
Aug 03, 2017 - Shares plunge after the company reports dreadful second-quarter results and slashes its dividend payment.
Aug 03, 2017 - Allergan Plc (NYSE:AGN)Q2 2017 Earnings CallAugust 03, 2017 8:30 am ETExecutivesDaphne Karydas - Allergan PlcBrenton L. Saunders - Allergan PlcWilliam J. Meury - Allergan PlcC. David Nicholson, Ph.D.
Sep 11, 2017 - An announcement from Allergan of a novel way to defend against patent challenges could be just what Pfizer needs.